Weight Loss Injections UK 2026: Complete Clinician-Led Guide
How prescription weight loss injections work, who they’re suitable for, and what to expect from clinician-led private treatment in the UK.
Clinically reviewed by
Shadeia Younis, Superintendent Pharmacist (GPhC 2052119)
Prescription weight loss injections are increasingly used in the UK as part of clinically supervised weight-management care. For people who have struggled to achieve sustainable weight loss through lifestyle changes alone, these medications may offer structured support when prescribed appropriately and monitored safely.
This guide explains how weight loss injections work, who they are suitable for, how they are prescribed legally in the UK, and what results are realistic. It reflects UK clinical standards and the clinician-led approach used at Slinic.
What this guide covers
Available medications, eligibility, side-by-side comparison of Mounjaro vs Wegovy vs Saxenda, realistic results, safety and monitoring, how online prescribing works in the UK, transparent pricing, and answers to the questions patients ask most.
Quick Answer: Weight Loss Injections in the UK 2026
- Three main options: Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide) — all prescription-only
- Clinical effectiveness: SURMOUNT-1 showed Mounjaro produced ~22.5% mean weight loss at 15mg; SURMOUNT-5 head-to-head: tirzepatide 20.2% vs semaglutide 13.7%
- Eligibility: Privately, BMI 30+ (or 27+ with a weight-related condition); NHS access under NICE TA1026 is very restricted
- Prescribed safely online: Legal and routine when delivered by a GPhC-registered pharmacy with UK-registered prescribers
- Slinic pricing: Mounjaro from £139/month, Wegovy from £99.99/month — pharmacist consultation and delivery included
- Long-term treatment: Most patients require ongoing therapy to maintain results; some weight regain is common after stopping
What’s Covered in This Guide
- 1What Are Weight Loss Injections?
- 2Which Injections Are Available in the UK?
- 3Who Is Eligible?
- 4Mounjaro vs Wegovy vs Saxenda Compared
- 5What Results Are Realistic?
- 6Safety, Side Effects & Monitoring
- 7How They’re Prescribed Online
- 8Pricing & Cost Considerations
- 9Slinic’s Pharmacist-Led Model
- 10Related Treatment Guides
- 11Frequently Asked Questions
What Are Weight Loss Injections?
Weight loss injections are prescription-only medicines that help regulate appetite and fullness by mimicking natural hormones involved in hunger and digestion. In the UK, they are prescribed by clinicians following a medical assessment and are used alongside lifestyle support.
They work by targeting receptors in the body that influence how hungry you feel, how quickly food leaves the stomach, and how your body manages energy. This can help reduce appetite, support smaller portions, and make sustainable eating patterns feel more achievable.
These medications are not meal replacements or quick fixes — they are medical treatments designed to work alongside lifestyle changes, not instead of them. The MHRA Summary of Product Characteristics and NICE TA1026 both specify that tirzepatide is intended for use alongside a reduced-calorie diet and increased physical activity.
For a deeper explanation of the mechanism, see our guide on how Mounjaro works for weight loss.
Which Weight Loss Injections Are Available in the UK?
The three main weight loss injections prescribed privately in the UK are:
| Medication | Active Ingredient | Frequency | Mechanism | Manufacturer |
|---|---|---|---|---|
| Mounjaro | Tirzepatide | Once weekly | Dual GLP-1 + GIP receptor agonist | Eli Lilly |
| Wegovy | Semaglutide | Once weekly | GLP-1 receptor agonist | Novo Nordisk |
| Saxenda | Liraglutide | Once daily | GLP-1 receptor agonist | Novo Nordisk |
Each has a different profile in terms of dosing, mechanism, and how patients experience treatment. The dual receptor activity of Mounjaro (acting on both GLP-1 and GIP receptors) is the basis for the superior weight loss results recorded in the SURMOUNT-5 head-to-head trial.
For detailed comparisons: Mounjaro vs Wegovy | Wegovy vs Saxenda
Who Is Eligible for Weight Loss Injections in the UK?
Eligibility is assessed using UK-recognised clinical principles. Privately, patients may be suitable based on:
- BMI of 30 or above, or
- BMI of 27 or above with a weight-related health condition such as:
- High blood pressure
- Type 2 diabetes or insulin resistance
- Polycystic ovary syndrome (PCOS)
- Obstructive sleep apnoea
- High cholesterol
Each case is assessed individually during the consultation. For Mounjaro-specific eligibility detail: Mounjaro UK eligibility 2026. For Wegovy: complete Wegovy patient guide.
When treatment may not be suitable
Weight loss injections may not be appropriate if you:
- Are pregnant, breastfeeding, or planning pregnancy
- Have a personal or family history of medullary thyroid carcinoma
- Have Multiple Endocrine Neoplasia syndrome type 2
- Have certain gastrointestinal conditions (severe gastroparesis, pancreatitis history)
- Have had a previous serious allergic reaction to the medication
- Are unable to engage with follow-up and monitoring
NHS Eligibility (Much More Restricted)
NICE approved tirzepatide for weight management under TA1026 (December 2024), but NHS England is rolling this out over a phased timeline of up to 12 years with strict criteria — typically BMI 40+ plus 4 of 5 specific conditions (Type 2 diabetes, hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea). Most patients with obesity do not currently meet NHS criteria.
Thinking About Starting Weight Loss Treatment?
The Slinic consultation takes around three minutes, and a pharmacist reviews your information within 24 hours. Pricing is transparent from your very first dose.
Start Your Confidential ConsultationMounjaro vs Wegovy vs Saxenda: Side-by-Side
There is no single “best” option. Clinicians assess suitability based on safety, tolerance, and long-term goals.
| Feature | Mounjaro | Wegovy | Saxenda |
|---|---|---|---|
| Mechanism | Dual (GLP-1 + GIP) | GLP-1 | GLP-1 |
| Frequency | Once weekly | Once weekly | Once daily |
| Dose range | 2.5mg – 15mg | 0.25mg – 2.4mg | 0.6mg – 3.0mg |
| Trial weight loss (max dose) | ~22.5% (SURMOUNT-1) | ~15% (STEP-1) | ~8% (SCALE) |
| Titration period | ~20 weeks to max | ~16 weeks to max | ~5 weeks to max |
| Slinic monthly cost | £139 – £285 | £99.99 – £209.99 | Available on request |
For detailed comparisons:
For dosing detail: Mounjaro dosing schedule | Wegovy dosages explained
What Results Are Realistic?
Weight loss injections support gradual, sustainable weight loss rather than rapid changes. Results vary between individuals based on starting weight, dose, lifestyle factors, and adherence.
Clinical Trial Results
- Mounjaro (SURMOUNT-1, NEJM 2022): Mean weight loss ~16% at 5mg, ~21.4% at 10mg, ~22.5% at 15mg over 72 weeks. 89-96% of participants achieved at least 5% weight loss.
- Wegovy (STEP-1, NEJM 2021): Mean weight loss ~15% at 2.4mg maintenance over 68 weeks.
- Head-to-head (SURMOUNT-5, NEJM 2025): Tirzepatide achieved 20.2% mean weight loss vs 13.7% for semaglutide over 72 weeks.
What to Expect in Practice
Generally, patients can expect:
- Appetite changes within the first 1-2 weeks of starting treatment
- Modest weight loss in the first month (2-4kg at starter doses)
- More noticeable weight loss as doses titrate up to therapeutic levels
- Steady progress over months, not days
- Results that build with consistency and clinician-led support
For realistic timelines: how long Mounjaro takes to work | how fast you can lose weight on Wegovy | Mounjaro results week by week.
Why gradual progress matters
Slower, steadier weight loss is easier to maintain long-term, kinder to your body, and less disruptive to energy and daily life. Habits are easier to sustain when progress feels manageable — and clinical evidence supports gradual titration as the way to reach maintenance doses with the best tolerability.
Safety, Side Effects & Monitoring
Common side effects are usually digestive and temporary, including:
- Nausea (most common during dose increases, typically settles within 1-2 weeks)
- Feeling full quickly
- Mild bloating, constipation, or diarrhoea
- Temporary fatigue
Clinician-led monitoring ensures safety throughout treatment, with dose reviews, side-effect management, and plan adjustments as needed. Severe adverse events in clinical trials were comparable to placebo.
For detailed side-effect guidance: Mounjaro side effects | Wegovy side effects
For practical food advice during treatment: GLP-1 meal plan UK | free Mounjaro meal plan.
Important safety information
Contraceptives: Mounjaro may reduce the effectiveness of oral contraceptives. The MHRA recommends adding a barrier method for 4 weeks after starting treatment and for 4 weeks after each dose increase, or switching to non-oral methods (coil, implant).
Pre-surgery: Inform your surgeon that you take a weight loss injection. These medications can increase aspiration risk during anaesthesia due to delayed gastric emptying.
When to seek urgent medical help
Severe abdominal pain, persistent vomiting preventing hydration, signs of pancreatitis, or allergic reactions require immediate medical attention. Contact your provider or NHS 111.
How Weight Loss Injections Are Prescribed Online in the UK
Online prescribing is legal and routine in the UK when carried out by UK-registered prescribers and dispensed by a GPhC-regulated pharmacy. Online consultations follow the same clinical and legal standards as face-to-face care.
The Process
Complete a Secure Medical Questionnaire
Comprehensive online assessment covering weight, height, medical history, current medications, and weight loss attempts. Takes around three minutes.
Clinical Review by a UK-Registered Prescriber
A qualified prescriber reviews your assessment for eligibility, suitable medication, appropriate starting dose, and any contraindications.
Prescription Issued if Suitable
If treatment is appropriate, a prescription is issued. If not, you’ll receive clear feedback on why and what alternatives may be appropriate.
Medication Dispensed by a Regulated Pharmacy
Clinically verified by the superintendent pharmacist before dispensing. Temperature-controlled, discreet delivery to your address.
Ongoing Pharmacist-Led Support
Regular clinical reviews monitor progress, manage side effects, and guide dose progression at the pace that’s right for you.
For more detail: how online consultations work | how private prescriptions work | legality of buying Mounjaro online | online clinics vs high street pharmacies.
Pricing & Cost Considerations
Costs vary by medication, dose, and level of clinical support. When comparing providers, patients should consider safety, clinical oversight, and what’s included — not the headline price alone.
Slinic Transparent Monthly Pricing
| Treatment | Starter Dose | Maintenance Range | Maximum Dose |
|---|---|---|---|
| Mounjaro | £139 (2.5mg) | £255 (10mg) – £275 (12.5mg) | £285 (15mg) |
| Wegovy | £99.99 (0.25mg) | £149.99 (1mg) – £174.99 (1.7mg) | £209.99 (2.4mg) |
Included in every monthly price: medication, pharmacist consultation, ongoing clinical reviews, and delivery. No consultation fees, no prescription charges, no subscription tiers.
For full pricing detail: complete Mounjaro cost breakdown UK 2026 | Wegovy cost UK 2026 | cheap weight loss injections UK.
For provider comparison: best Mounjaro provider UK 2026.
What to check when comparing providers
- Are consultation fees included or separate?
- Is follow-up clinical support part of the price?
- Are delivery and supplies bundled?
- How does the price change as you progress up the dose ladder?
- Is the pharmacy GPhC-registered? What’s the registration number?
- Who is the named superintendent pharmacist?
Slinic’s Pharmacist-Led Model
Slinic is a GPhC-registered online pharmacy (GPhC: 1033729) specialising in weight loss treatments. Every prescription is clinically verified by a qualified pharmacist before dispensing — and ongoing clinical oversight is included in the monthly price, not charged as an extra.
Shadeia Younis
Superintendent Pharmacist, Slinic (GPhC 2052119)
Every Mounjaro and Wegovy prescription dispensed by Slinic is clinically verified and overseen by Shadeia Younis, our superintendent pharmacist. That means before your medication leaves our pharmacy it has been checked by a qualified, registered professional who is accountable for its safety.
This level of oversight is not standard across all online providers. Pharmacist-led dispensing means a real clinical expert reviews your treatment at every stage — and at Slinic, that oversight is included in the monthly price rather than charged separately.
What Pharmacist-Led Care Means in Practice
- Initial consultation reviewed by a qualified pharmacist — not approved by automated questionnaire
- Dose progression guided by clinical judgement, not a rigid escalation calendar
- Side effect management with real clinical input when nausea hits or a dose increase feels too much
- Continuity of care across the full treatment journey, not just at the point of purchase
For more on how the Slinic process works from consultation through to delivery: how online consultations for weight loss injections work.
Medical references and guidance
Clinical guidance in this article is based on the MHRA Summary of Product Characteristics for Mounjaro (tirzepatide) and Wegovy (semaglutide). Trial data is from SURMOUNT-1 (NEJM 2022), STEP-1 (NEJM 2021), SURMOUNT-4 (JAMA 2024), and SURMOUNT-5 (NEJM 2025). NICE Technology Appraisal TA1026 covers tirzepatide for weight management in adults (published December 2024). All medical facts in Slinic content are verified against MHRA, NICE, NHS, and BNF sources.
Frequently Asked Questions
Yes, when prescribed by a UK-registered clinician and dispensed by a GPhC-regulated pharmacy. Medications like Mounjaro and Wegovy are prescription-only medicines with established safety profiles in clinical trials when used under appropriate medical supervision. In SURMOUNT-1 (NEJM 2022) and STEP-1 (NEJM 2021), serious adverse events were comparable to placebo.
Yes. All weight loss injections available in the UK are prescription-only medicines. They require a medical consultation and clinical review before they can be prescribed and dispensed. Purchasing from unregulated sources carries serious risks including counterfeit medication.
Yes, online prescribing is legal when carried out by UK-registered prescribers and dispensed by a GPhC-regulated pharmacy. Online consultations follow the same clinical and legal standards as face-to-face care. See our guide on the legality of buying Mounjaro online.
There is no single best option. Mounjaro targets two receptors (GLP-1 and GIP), Wegovy targets GLP-1, and Saxenda also targets GLP-1 but is taken daily. The SURMOUNT-5 head-to-head trial (NEJM 2025) showed tirzepatide achieved 20.2% mean weight loss vs 13.7% for semaglutide. Clinicians assess suitability based on your health profile, tolerance, and long-term goals. See our Mounjaro vs Wegovy comparison.
Treatment duration varies. NICE TA1026 and MHRA guidance recognise tirzepatide as a long-term treatment for adults with obesity. Some patients use injections for a defined period, others as part of longer-term weight management. This is discussed during consultation and reviewed as treatment progresses. See how long can you stay on Mounjaro.
Some weight regain is common if medication is stopped, particularly if lifestyle changes are not maintained. The SURMOUNT-4 trial (JAMA 2024) showed that patients continuing tirzepatide maintained their weight loss whilst those switched to placebo regained significantly. Gradual, supported treatment plans help build sustainable habits alongside medication.
Common side effects like nausea are usually mild and temporary, typically settling within one to two weeks at any given dose. If side effects are persistent or uncomfortable, your prescriber can adjust doses, slow progression, or discuss alternatives. See our full Mounjaro side effects guide.
Tirzepatide was approved by NICE under TA1026 (December 2024), but NHS England is rolling this out over a phased timeline of up to 12 years with strict eligibility criteria – typically requiring BMI 40+ plus 4 of 5 specific weight-related conditions (Type 2 diabetes, hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea). Most patients with obesity currently don’t qualify, so private prescribing through a GPhC-registered pharmacy remains the realistic route.
At Slinic, transparent monthly pricing is:
- Mounjaro: £139 (2.5mg) – £285 (15mg)
- Wegovy: £99.99 (0.25mg) – £209.99 (2.4mg)
All prices include medication, pharmacist consultation, ongoing clinical reviews, and delivery — no hidden fees. For full breakdown, see our Mounjaro cost UK 2026 guide and Wegovy cost UK 2026 guide.
Both routes use the same licensed medication (genuine Eli Lilly Mounjaro or Novo Nordisk Wegovy) and the same clinical guidelines. The difference is access: NHS routes have strict eligibility criteria and long waiting times due to the phased TA1026 rollout, whilst private prescribing through a GPhC-registered pharmacy offers faster access with the same legal and clinical standards. See how private prescriptions work in the UK.
Yes, but only under clinical supervision. Patients sometimes switch from Wegovy to Mounjaro for greater effectiveness, or from Mounjaro to Wegovy for budget reasons during maintenance. The transition needs careful dose planning. See switching from Wegovy to Mounjaro or swapping from Mounjaro to Wegovy.
Ready to Explore Your Options?
If you’re considering weight loss injections and want clinician-led guidance tailored to your health and goals, a medical consultation is the best place to start.
With Slinic, you’ll receive
- A structured medical assessment by a UK-registered prescriber
- Clear guidance on which treatment may suit you based on your health profile
- Personalised dose planning and realistic expectations
- Ongoing pharmacist-led clinical support throughout treatment
- Transparent monthly pricing with delivery included
Ready to Start Treatment?
The Slinic online consultation takes around three minutes. A pharmacist reviews your information within 24 hours.
Complete Our Online ConsultationMedical Disclaimer
This article provides educational information about prescription weight loss injections in the UK and is not a substitute for professional medical advice. Mounjaro, Wegovy, and Saxenda are prescription-only medicines and should only be used together with a reduced-calorie diet and increased physical activity under appropriate clinical supervision. Always consult qualified healthcare providers before starting weight loss medication. Individual results vary. Prices correct as of April 2026 and may be subject to change.
Related Blog Posts From Slinic
Ozempic vs Mounjaro vs Wegovy UK: The Specialist Guide – a specialist guide to the key differences between Ozempic, Mounjaro and Wegovy in the UK.
Evidence-Based Weight Loss in the UK: A Clinical Guide for 2026 – a clinical guide to evidence-based weight loss in the UK for 2026.
Weight Loss Injection: The Specialist Clinical Guide – a specialist clinical guide to medical weight management in the UK.